Cobicistat and elvitegravir and emtricitabine and tenofovir only product in oral dose form
|
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet
Id734150006
StatusDefined
Has manufactured dose formOral tablet
Has unit of presentationTablet
Has BoSSElvitegravir
Has precise active ingredientElvitegravir
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSTenofovir alafenamide
Has precise active ingredientTenofovir alafenamide fumarate
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSCobicistat
Has precise active ingredientCobicistat
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg
Has BoSSEmtricitabine
Has precise active ingredientEmtricitabine
Has presentation strength denominator unitTablet
Has presentation strength numerator unitmg